Serena Williams faces criticism for weight-loss drug ad at Cincinnati Open

Serena Williams is preparing for her appearance at the Cincinnati Open after her recent Wimbledon exit. She sparked controversy with an aerial advertisement for a GLP-1 weight-loss drug, displayed via a high-flying banner above the courts. The ad features Williams self-administering the medication, which has drawn widespread critique from fans and commentators. Critics argue that Williams' promotion of weight-loss methods could suggest shortcuts to achieving a desired physique. Williams has publicly discussed her experience with GLP-1 drugs, crediting them for her weight loss and improved health metrics. She is set to team up with her sister Venus Williams in doubles at the tournament.

• 10:34 AMYahoo Sports — “This Is So Dystopian”; “Ridiculous” – Tennis Fans React to Serena Williams’ Weight-Loss Drug Advertisement Stunt at Cincinnati Open